Merck : MRK

All Merck Articles

1067 Articles

Paul Ausick | Aug 25, 2015 at 4:01 PM EDT

The 4 Stocks That Weighed on the DJIA Tuesday

thinkstockAugust 25, 2015: Markets opened higher on Tuesday and the markets quickly shook of the remaining effects of Monday’s tank…

Jon C. Ogg | Aug 21, 2015 at 1:35 PM EDT

4 Defensive Stocks Acting as a Buffer Against the Market Sell-Off

Some investors are looking at value stocks, and others are going defensive. The stocks that have limited business cycles are…

Paul Ausick | Aug 20, 2015 at 4:01 PM EDT

The 4 Stocks That Tanked the Dow on Thursday

thinkstockAugust 20, 2015: Markets opened lower on Thursday and things got worse from there. The bad news started in China,…

Lee Jackson | Aug 18, 2015 at 8:22 AM EDT

4 Top Pharma Stocks That Should Outperform Out To 2016

ThinkstockWith a very nervous market, and the end of summer doldrums upon us, it may be time to look for…

Paul Ausick | Aug 13, 2015 at 4:01 PM EDT

The 4 Stocks That Held the DJIA Higher on Thursday

thinkstockAugust 13, 2015: Markets opened slightly higher on Thursday following reassurances from the People’s Bank of China that it is…

Jon C. Ogg | Aug 13, 2015 at 8:40 AM EDT

Top Analyst Upgrades and Downgrades: Alibaba, Baker Hughes, GoPro, Merck, Microsoft, Yahoo and Many More

Thursday's top analyst upgrades, downgrades and initiations include Alibaba, Baker Hughes, GoPro, Merck, Microsoft and Yahoo.

Chris Lange | Aug 12, 2015 at 9:45 AM EDT

Short Sellers Back Off Big Pharma

The short interest data have been released for the July 31 settlement date, and for most of the selected pharmaceutical…

Lee Jackson | Aug 6, 2015 at 8:35 AM EDT

4 Large Cap Pharmaceutical Stocks to Buy on Strong Health Care Trends

24/7 Wall St. screened the Merrill Lynch health care universe and found four pharmaceutical stocks rated Buy with outstanding short-term…

Lee Jackson | Aug 4, 2015 at 9:35 AM EDT

UBS Makes August Changes to Equity Focus List Portfolio

In a new report, UBS made changes in the firm's Equity Focus list and updated other positions.

Chris Lange | Aug 3, 2015 at 11:05 AM EDT

Positive Developments Around Ebola

Ebola fears have subsided and the development of a vaccine or related drugs has been put on the back burner…

Paul Ausick | Jul 29, 2015 at 4:01 PM EDT

The 4 Stocks That Boosted the DJIA on Wednesday

thinkstockJuly 29, 2015: Markets opened higher on Wednesday and two of the three major indexes spend all day trading above…

Chris Lange | Jul 29, 2015 at 1:27 PM EDT

Should Gilead Really Be Rated Underperform?

ThinkstockMost analysts seem to be behind the growth that Gilead Sciences Inc. (NASDAQ: GILD) has seen, namely in its Hepatitis…

Chris Lange | Jul 28, 2015 at 9:55 AM EDT

Are Merck Earnings Enough?

ThinkstockMerck & Co. Inc. (NYSE: MRK) reported its second-quarter financial results Tuesday before the markets opened. The pharmaceutical giant had…

Chris Lange | Jul 27, 2015 at 1:40 PM EDT

What to Expect from Merck Earnings

ThinkstockMerck & Co. Inc. (NYSE: MRK) reports on Tuesday morning comes into earnings with shares up only 2.7% or so…

Chris Lange | Jul 27, 2015 at 8:21 AM EDT

Short Sellers Run For Cover From Major Pharma

ThinkstockThe short interest data have been released for the July 15 settlement date. Pharmaceutical companies are usually involved in a…

1 … 40 41 42 43 44 … 72

Merck : MRK

All Merck Articles

The 4 Stocks That Weighed on the DJIA Tuesday

4 Defensive Stocks Acting as a Buffer Against the Market Sell-Off

The 4 Stocks That Tanked the Dow on Thursday

4 Top Pharma Stocks That Should Outperform Out To 2016

The 4 Stocks That Held the DJIA Higher on Thursday

Top Analyst Upgrades and Downgrades: Alibaba, Baker Hughes, GoPro, Merck, Microsoft, Yahoo and Many More

Short Sellers Back Off Big Pharma

4 Large Cap Pharmaceutical Stocks to Buy on Strong Health Care Trends

UBS Makes August Changes to Equity Focus List Portfolio

Positive Developments Around Ebola

The 4 Stocks That Boosted the DJIA on Wednesday

Should Gilead Really Be Rated Underperform?

Are Merck Earnings Enough?

What to Expect from Merck Earnings

Short Sellers Run For Cover From Major Pharma

Jill Schlesinger Greenlights $2.9M Retiree’s $200K Gift to Sons: ‘I Can’t Believe I’m Being the Dream Maker’

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts

Rivian Tops Q1 Estimates, but Investors Investors Rightly Remain Wary

Jill Schlesinger Greenlights $2.9M Retiree's $200K Gift to Sons: 'I Can't Believe I'm Being the Dream Maker'

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts

Jill Schlesinger Greenlights $2.9M Retiree’s $200K Gift to Sons: ‘I Can’t Believe I’m Being the Dream Maker’

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts

Merck : MRK

All Merck Articles

The 4 Stocks That Weighed on the DJIA Tuesday

4 Defensive Stocks Acting as a Buffer Against the Market Sell-Off

The 4 Stocks That Tanked the Dow on Thursday

4 Top Pharma Stocks That Should Outperform Out To 2016

The 4 Stocks That Held the DJIA Higher on Thursday

Top Analyst Upgrades and Downgrades: Alibaba, Baker Hughes, GoPro, Merck, Microsoft, Yahoo and Many More

Short Sellers Back Off Big Pharma

4 Large Cap Pharmaceutical Stocks to Buy on Strong Health Care Trends

UBS Makes August Changes to Equity Focus List Portfolio

Positive Developments Around Ebola

The 4 Stocks That Boosted the DJIA on Wednesday

Should Gilead Really Be Rated Underperform?

Are Merck Earnings Enough?

What to Expect from Merck Earnings

Short Sellers Run For Cover From Major Pharma

Jill Schlesinger Greenlights $2.9M Retiree’s $200K Gift to Sons: ‘I Can’t Believe I’m Being the Dream Maker’

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts

Rivian Tops Q1 Estimates, but Investors Investors Rightly Remain Wary

Featured Reads

Jill Schlesinger Greenlights $2.9M Retiree's $200K Gift to Sons: 'I Can't Believe I'm Being the Dream Maker'

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts